The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Images in Clinical Medicine
PreviousPrevious
Volume 356:841 February 22, 2007 Number 8
NextNext

Central Retinal Artery Occlusion

 

This Article
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Figure 1
View larger version (78K):
[in this window]
[in a new window]
Get Slide
 
A 76-year-old man with hypertension presented with a sudden, painless, and profound loss of vision in the right eye. Visual acuity was light perception only in the affected eye, with a positive relative afferent pupillary defect. Ophthalmoscopic examination revealed diffuse retinal whitening, constriction of the arteriole and venule with segmentation (Panel A, arrowhead), and a cherry-red spot in the macula (Panel A, arrow) — all signs compatible with the diagnosis of central retinal artery occlusion. A horizontally oriented optical coherence tomograph of the macula (Panel B, arrowhead) demonstrated increased thickness and reflectivity of the inner bands, indicating ischemic damage to the nerve fiber and adjacent layers (Panel B, arrow).

Therapy for this condition remains unclear. However, given the sight-threatening nature of the lesion, ocular massage and paracentesis of the anterior chamber were performed but were unsuccessful in improving the patient's vision. Further evaluation for an underlying cause was unrevealing, with a normal erythrocyte sedimentation rate, C-reactive protein level, and echocardiogram. Ultrasonography of the carotid arteries demonstrated stenosis of less than 50% on the right side.

Central retinal artery occlusion is associated with a variety of medical conditions, including embolic events and rheumatologic conditions, such as temporal arteritis. Since no specific cause was identified in this case, the patient was given antiplatelet therapy only. Optic atrophy developed within 12 weeks, and the patient has continued to perceive only light in the affected eye.

 

Kayvan Arashvand, M.D.
Southend Hospital
Westcliff-on-Sea, Essex SS0 0RY, United Kingdom
k_arashvand{at}yahoo.com




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.